Related Experiment Video
Updated: Aug 11, 2025

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Examination of methadone involved overdoses during the COVID-19 pandemic
Daniel E Kaufman1, Amy L Kennalley2, Kenneth L McCall3
1Touro College of Osteopathic Medicine, Middletown, NY, USA.
Background:
The US opioid overdose epidemic continues to escalate. The restrictions on methadone availability including take-home dosing were loosened during the COVID-19 pandemic although there have been concerns about the high street value of diverted methadone. This report examined how fatal overdoses involving methadone have changed over the past two-decades including during the pandemic.
Methods:
The CDC's Wide-ranging Online Data for Epidemiologic Research (WONDER) was used to find the unintentional methadone related overdose death rate from 1999 to 2020. Unintentional methadone deaths were defined using the ICD X40-44 codes with only data for methadone (T40.3). Data from the DEA's Automation of Reports and Consolidated Orders System (ARCOS) on methadone overall use, opioid treatment programs use, and pain management use was gathered for all states for 2020 and corrected for population.
Results:
There have been dynamic changes over the past two-decades in methadone overdoses. Overdoses increased from 1999 (0.9/million) to 2007 (15.9) and declined until 2019 (6.5). Overdoses in 2020 (9.6) were 48.1% higher than in 2019 (t(50) = 3.05, p < .005). The state level correlations between overall methadone use (r(49) = +0.75, p < .001), and opioid treatment program use (r(49) = +0.77, p < .001) with overdoses were positive, strong, and statistically significant. However, methadone use for pain treatment was not associated with methadone overdoses (r(49) = -0.08).
Conclusions:
Overdoses involving methadone significantly increased by 48.1% in 2020 relative to 2019. Policy changes that were implemented following the COVID-19 pandemic involving methadone take-homes may warrant further study before they are made permanent.
Insights
Methadone overdose deaths surged by 48.1% in 2020, reversing a downward trend. This highlights the need for careful review of policy changes, like methadone take-home doses, amidst the ongoing opioid crisis.
Area of Science:
- Public Health
- Epidemiology
- Pharmacology
Background:
- The US opioid overdose epidemic remains a critical public health concern.
- Methadone availability, including take-home dosing, was altered during the COVID-19 pandemic.
- Concerns exist regarding the diversion and street value of methadone.
Purpose of the Study:
- To analyze trends in fatal methadone-related overdoses over two decades, including the pandemic period.
- To investigate the relationship between methadone usage patterns and overdose rates.
Main Methods:
- Utilized CDC WONDER data (1999-2020) for unintentional methadone overdose death rates (ICD X40-44, T40.3).
- Incorporated DEA ARCOS data on methadone use (overall, OTP, pain management) for 2020, population-corrected.
- Employed correlation analyses to assess associations between methadone use and overdose deaths.
Main Results:
- Methadone overdose deaths increased from 0.9/million in 1999 to a peak of 15.9 in 2007, then declined to 6.5 in 2019.
- A significant 48.1% increase in methadone overdose deaths occurred in 2020 compared to 2019.
- Strong positive correlations were found between overall methadone use and opioid treatment program use with overdose rates, but not with pain management use.
Conclusions:
- Fatal methadone overdoses saw a substantial rise in 2020, underscoring the evolving nature of the opioid crisis.
- The study suggests that policy modifications, particularly those concerning methadone take-home policies implemented during the pandemic, require thorough evaluation.
- Further research is recommended to inform future policy decisions regarding methadone access and safety.
More Related Videos
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Abuse and Addiction: Pharmacological Phenomena
Analgesia and Pain Management
Drug Dependence
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...